Evidence map›Paper›PMID 30696688›Full record

ArticleThe EMBO journal2019

The herpesviral antagonist m152 reveals differential activation of STING-dependent IRF and NF-κB signaling and STING's dual role during MCMV infection.

Markus Stempel, Baca Chan, Vanda Juranić Lisnić, Astrid Krmpotić, Josephine Hartung, Søren R Paludan, Nadia Füllbrunn, Niels Aw Lemmermann, Melanie M Brinkmann

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Markus StempelViral Immune Modulation Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.ORCID 0000-0002-9240-3987
Baca ChanViral Immune Modulation Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Vanda Juranić LisnićCenter for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Astrid KrmpotićCenter for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Josephine HartungViral Immune Modulation Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Søren R PaludanDepartment of Biomedicine, Aarhus Research Center for Innate Immunology, University of Aarhus, Aarhus, Denmark.ORCID 0000-0001-9180-4060
Nadia FüllbrunnViral Immune Modulation Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Niels Aw LemmermannInstitute for Virology and Research Center for Immunotherapy, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.ORCID 0000-0001-9190-6497
Melanie M BrinkmannViral Immune Modulation Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany m.brinkmann@tu-bs.de.ORCID 0000-0001-5431-6527
Helmholtz Centre for Infection Research · DEUniversity of Rijeka · HRAarhus University · DKJohannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytomegaloviruses (CMVs) are master manipulators of the host immune response. Here, we reveal that the murine CMV (MCMV) protein m152 specifically targets the type I interferon (IFN) response by binding to stimulator of interferon genes (STING), thereby delaying its trafficking to the Golgi compartment from where STING initiates type I IFN signaling. Infection with an MCMV lacking m152 induced elevated type I IFN responses and this leads to reduced viral transcript levels both

Indexed as

AnimalsCytomegalovirus InfectionsHost-Pathogen InteractionsInterferon Regulatory FactorsInterferon Type IMembrane GlycoproteinsMembrane ProteinsMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMuromegalovirusNF-kappa BProtein BindingSTING ProteinViral ProteinsInterferon Regulatory FactorsInterferon Type Im152 protein, cytomegalovirusMembrane GlycoproteinsMembrane ProteinsNF-kappa BSting1 protein, mouseSTING ProteinViral Proteinsherpesvirusinnate immunityIRF3NF‐κBSTING

Identifiers

PMID30696688
PMCPMC6396373
OpenAlexW2911646350

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.